Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$2.52 - $5.69 $9,946 - $22,458
3,947 Added 1.72%
233,431 $597,000
Q2 2023

Aug 10, 2023

BUY
$5.0 - $7.66 $66,990 - $102,628
13,398 Added 6.2%
229,484 $1.24 Million
Q1 2023

May 09, 2023

BUY
$3.54 - $6.66 $71,996 - $135,451
20,338 Added 10.39%
216,086 $1.38 Million
Q4 2022

Feb 10, 2023

BUY
$2.11 - $4.3 $1,985 - $4,046
941 Added 0.48%
195,748 $841,000
Q3 2022

Nov 10, 2022

BUY
$2.13 - $4.0 $28,075 - $52,724
13,181 Added 7.26%
194,807 $442,000
Q2 2022

Aug 05, 2022

BUY
$1.88 - $3.42 $300,982 - $547,531
160,097 Added 743.63%
181,626 $536,000
Q1 2022

May 12, 2022

BUY
$2.06 - $3.0 $44,349 - $64,587
21,529 New
21,529 $62,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $40.5M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.